Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 2
1980 2
1981 3
1982 4
1983 4
1984 4
1985 3
1986 2
1987 7
1988 6
1989 2
1991 2
1993 2
1994 2
1995 1
1996 2
1997 3
1998 3
1999 6
2000 3
2001 2
2002 3
2003 1
2004 4
2005 4
2006 2
2007 3
2008 1
2009 2
2010 4
2011 3
2012 3
2013 4
2014 2
2015 8
2016 6
2017 2
2018 5
2019 5
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
ANA-Negative Lupus Presenting with Heart Failure and Severe Valvular Dysfunction: Case Report and Review of the Literature.
Hoang V, Addison D, Lakkis N, Tabbaa R. Hoang V, et al. Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):186-8. doi: 10.14797/mdcj-11-3-186. Methodist Debakey Cardiovasc J. 2015. PMID: 26634028 Free PMC article. Review.
Antinuclear antibody (ANA) negative lupus is an important subset of the systemic lupus erythematosus (SLE) disease spectrum. Since the introduction of human cell line for ANA assay, the occurrence of true ANA-negative
Antinuclear antibody (ANA) negative lupus is an important subset of the systemic lupus erythematosus
Cutaneous Lupus Erythematosus Patients With a Negative Antinuclear Antibody Meeting the American College of Rheumatology and/or Systemic Lupus International Collaborating Clinics Criteria for Systemic Lupus Erythematosus.
Tarazi M, Gaffney RG, Kushner CJ, Chakka S, Werth VP. Tarazi M, et al. Arthritis Care Res (Hoboken). 2019 Nov;71(11):1404-1409. doi: 10.1002/acr.23916. Arthritis Care Res (Hoboken). 2019. PMID: 31058462
OBJECTIVE: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One hallmark of the disease is the presence of antinuclear antibodies (ANAs), a feature that has been incorporated into multiple classification …
OBJECTIVE: Systemic lupus erythematosus (SLE) is a disorder that is heterogeneous and can be difficult to diagnose. One …
Antinuclear antibody-negative lupus? An ominous presentation of hydralazine-induced lupus syndrome.
Solomon-Tsegaye T, Treadwell EL, Obi R, Pitzalis M. Solomon-Tsegaye T, et al. Eur J Rheumatol. 2018 Dec;5(4):272-274. doi: 10.5152/eurjrheum.2018.18040. Epub 2018 Jun 20. Eur J Rheumatol. 2018. PMID: 30071945 Free PMC article.
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus syndrome (DILS). Antinuclear antibody (ANA) should be present to diagnose SLE and DILS. ANA-negative lupus is …
Up to 10% of systemic lupus erythematosus (SLE) cases are drug-induced; hence, they are called drug-induced lupus
ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.
Changal KH, Sofi F, Altaf SS, Raina A, Raina AH. Changal KH, et al. Case Rep Rheumatol. 2016;2016:4507247. doi: 10.1155/2016/4507247. Epub 2016 Feb 24. Case Rep Rheumatol. 2016. PMID: 27006850 Free PMC article.
We describe a case of ANA negative SLE with severe thrombocytopenia, cutaneous vasculitis, antiphospholipid antibody syndrome, and pulmonary artery hypertension. ...
We describe a case of ANA negative SLE with severe thrombocytopenia, cutaneous vasculitis, antiphospholipid antibody syndrome, …
Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature.
Simmons SC, Smith ML, Chang-Miller A, Keddis MT. Simmons SC, et al. Am J Nephrol. 2015;42(6):451-9. doi: 10.1159/000443747. Epub 2016 Jan 27. Am J Nephrol. 2015. PMID: 26812129 Free article.
Lupus nephritis (LN) is a serious and common complication of systemic lupus erythematosus (SLE) that predisposes to significant morbidity and mortality. ...The absence of SLE-related serologies should be weighed against a high pre-test probability of
Lupus nephritis (LN) is a serious and common complication of systemic lupus erythematosus (SLE) that predisposes
ANA-negative SLE.
Maddison PJ. Maddison PJ. Clin Rheum Dis. 1982 Apr;8(1):105-19. Clin Rheum Dis. 1982. PMID: 6749392 Review. No abstract available.
Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE.
Pisetsky DS, Spencer DM, Lipsky PE, Rovin BH. Pisetsky DS, et al. Ann Rheum Dis. 2018 Jun;77(6):911-913. doi: 10.1136/annrheumdis-2017-212599. Epub 2018 Feb 9. Ann Rheum Dis. 2018. PMID: 29440000
OBJECTIVE: The expression of antinuclear antibodies (ANA) is considered almost constant in systemic lupus erythematosus (SLE), although recent experience has suggested that many subjects with SLE considered for clinical trials are ANA negativ
OBJECTIVE: The expression of antinuclear antibodies (ANA) is considered almost constant in systemic lupus erythemato
ANA-Negative Presentation of SLE in Man with Severe Autoimmune Neutropenia.
Zhao M. Zhao M. Case Rep Med. 2016;2016:6853936. doi: 10.1155/2016/6853936. Epub 2016 Dec 19. Case Rep Med. 2016. PMID: 28077945 Free PMC article.
Systemic lupus erythematosus (SLE) is a chronic, inflammatory, connective tissue disease that commonly affects the joints and a variety of organs due to an overactivation of the body's immune system. ...Severe autoimmune neutropenia is uncommon and may correl
Systemic lupus erythematosus (SLE) is a chronic, inflammatory, connective tissue disease that commonly affects the join
ANA-negative systemic lupus erythematosus.
Pratap DV, Reddy SK, Rani SC, Krishna VA, Indira D. Pratap DV, et al. Indian J Dermatol Venereol Leprol. 2004 Jul-Aug;70(4):243-4. Indian J Dermatol Venereol Leprol. 2004. PMID: 17642626 Free article. No abstract available.
ANA-Negative Hydralazine-Induced Pericardial Effusion.
Zeitjian V, Mehdizadeh A. Zeitjian V, et al. Case Rep Med. 2017;2017:3521541. doi: 10.1155/2017/3521541. Epub 2017 Dec 17. Case Rep Med. 2017. PMID: 29391867 Free PMC article.
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrome due to hydralazine. ...As per our literature review, this is the second case of hydralazine causing DILE with a negative ANA
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrom …
125 results
Jump to page
Feedback